Results of Albiglutide Studies Are Satisfying, Says Glaxosmithkline PLCs
Submitted by Davell Wilkins on Tue, 04/03/2012 - 11:59On Tuesday, GlaxoSmithKline PLCs informed that seven results out of eight 'Harmony' Phase III studies have showed that the drug albiglutide is beneficial for patients affected with Type 2 diabetes.
New Alliance Formed To Fight Tropical Diseases
Submitted by Olivia Conroy on Tue, 01/31/2012 - 07:47As per reported information, it has got revealed that 13 drug makers and many health organizations have united with the government to eliminate 10 tropical diseases by 2020. Some of the known drug companies and health organizations which have taken the pledge with the government are Astra and Glaxo and the Bill and Melinda Gates Foundation.
Narcolepsy, a Side Effect of the Swine Flu Vaccine?
Submitted by Olivia Conroy on Tue, 12/13/2011 - 08:11A six years old boy was struck by narcolepsy and his parents are of the view that this has been the result of the swine flu vaccination the kid had just received.
African Malaria Vaccine Program Needs To Speed Up
Submitted by Jonathan Sanders on Wed, 10/19/2011 - 08:30A ray of hope has been found to cure people from malaria, as the initial results of the malaria vaccine, RTS, S have proven beneficial, and more than half of the malaria affected children, who received the vaccine, were found to be protected against the virus.
Swine Flu Vaccine Associated with Sleeping Disorder in Children and Teenagers
Submitted by Ria Patel on Fri, 07/22/2011 - 12:03GlaxoSmithKline, maker of a swine flu vaccine, has connected the flu to a sleeping disorder in the children and teenagers, as well as stated Australians were safe and not at risk.
FDA approves Glaxo’s triple vaccine ‘Boostrix’ for 65-plus patients
Submitted by Ria Patel on Sun, 07/10/2011 - 18:00On Friday, US Food and Drug Administration (FDA) gave its approval to GlaxoSmithKline's triple vaccine ‘Boostrix’ – which is a combination vaccine for tetanus, diphtheria and pertussis (whooping cough) - for patients aged more than 65 years.
Combination Vaccine Approved for Use on Seniors
Submitted by Olivia Conroy on Sat, 07/09/2011 - 08:55According to health regulators from the United States, GlaxoSmithKline’s combination vaccine, branded as Boostrix, has been approved for use on seniors.
Lack of Funds and Risk of Lawsuits Might Terminate Research Work for Mental Disorders
Submitted by Ria Patel on Wed, 06/15/2011 - 08:13Neuroscientists will no longer attempt for new research in mental disorders, states a news report. The leading drug companies like UK-based GlaxoSmithKline (GSK) and AstraZeneca declared that they will not work on the psychiatric medication in the treatments like depression, dysthymia and schizophrenia. This announcement is a setback to millions of people who suffer from such problems.
Pharmaceutical Companies to Pull Out Abruptly From Brain Disorder Drug Research
Submitted by Cindy Tweed on Tue, 06/14/2011 - 08:21Renowned drug companies, including UK-based GlaxoSmithKline and AstraZeneca, have announced that they do not intend to research new antidepressant drugs. A majority of senior scientists have warned that the decision will leave the families without hope along with a huge financial impact on society.
Epilepsy Pill Gets Restricted FDA Approval
Submitted by Olivia Conroy on Mon, 06/13/2011 - 13:54On Monday, the GlaxoSmithKline PLC and Canadian partner Valeant Pharmaceuticals International Inc. had announced to receive an approval from the U. S. drug regulators for their epilepsy pill Potiga, as an add-on treatment for partial onset seizures, which begins in one side of the brain.












